Companies

Ginkgo Bioworks Holdings, Inc. (DNA) SEC filings

CIK 0001830214 · Biological Products, (No Diagnostic Substances) (SIC 2836) · NYSE · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)170.2 M477.7 M
Net income (USD)-126.6 M-119.3 M
Diluted EPS (USD/shares)-5.64-50.2

Latest filings

FiledFormDescriptionPeriod
2026-10-214FORM 42026-10-16
2026-10-214FORM 42026-10-16
2026-10-214FORM 42026-10-16
2026-10-214FORM 42026-10-16
2026-10-19144144
2026-10-19144144
2026-10-19144144
2026-10-19144144
2026-10-19144144
2026-10-19144144
2026-10-074FORM 42026-10-05
2026-10-05144144
2026-09-17144144
2026-09-164FORM 42026-09-15
2026-09-15144144
2026-08-254FORM 42026-08-21
2026-08-24144144
2026-08-17144144
2026-08-0610-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-07-304FORM 42026-07-28
2026-07-304FORM 42026-07-28
2026-07-304FORM 42026-07-28
2026-07-308-K8-K items 7.01,9.012026-07-30
2026-07-30SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 144 689, 4 202, 8-K 33, 10-Q 10, SC 13G/A 10, SCHEDULE 13G/A 8, UPLOAD 6, CORRESP 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DNA (0.002 USD), /gw/filings/filings?ticker=DNA&form=8-K, /gw/filings/facts?ticker=DNA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange